--2025/Q1-- / 1.268M--
--2024/Q4-- / 1.701M--
--2024/Q33.336M / 1.520M--
--2024/Q22.658M / 1.289M--
--2024/Q11.717M / 1.213M--
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
CUE Cue Biopharma
- 1.010
- -0.010-0.98%
Close Dec 20 16:00 ET
- 1.010
- 0.0000.00%
Post 16:21 ET
63.98MMarket Cap-1.11P/E (TTM)
1.090High0.990Low624.25KVolume1.000Open1.020Pre Close644.88KTurnover0.99%Turnover RatioLossP/E (Static)63.35MShares3.20052wk High2.53P/B63.45MFloat Cap0.45052wk Low--Dividend TTM62.83MShs Float31.690Historical High--Div YieldTTM9.80%Amplitude0.450Historical Low1.033Avg Price1Lot Size
Cue Biopharma Key Stats
Cue Biopharma Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Cue Biopharma Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data